UPMC Cancer Centers works in tandem with the University of Pittsburgh Cancer Institute (UPCI), which comprises the academic and research activities for cancer at the University of Pittsburgh and UPMC, to offer patients the latest advances in cancer prevention, detection, diagnosis and treatment.
The Magee Gynecologic Cancer Program's particular area of research emphasis is the diagnosis and treatment of ovarian cancer. This effort is reflected in a vigorous program of basic and clinical research into biological therapies for ovarian cancer, as well as recently established initiatives aimed at understanding risk factors and biological markers for this disease.
Patients seen at the Magee Gynecologic Cancer Program have access to many innovative clinical trials, including National Cancer Institute cooperative group studies, industry-sponsored trials and unique, early phase protocols based on research conducted at UPCI.
For more detailed information on the Program's research activities, including current research, accomplishments and future directions, visit the Gynecologic Oncology Disease Site at the University of Pittsburgh Cancer Institute.